Dr. Baha Sibai, M.D

NPI: 1942381926
Total Payments
$130,256
2023 Payments
$8,327
Companies
16
Transactions
116

Payment Breakdown by Category

Consulting$119,812 (92.0%)
Food & Beverage$3,567 (2.7%)
Travel$2,225 (1.7%)
Other$2,000 (1.5%)
Research$1,694 (1.3%)
Education$957.78 (0.7%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $119,812 54 92.0%
Food and Beverage $3,567 33 2.7%
Travel and Lodging $2,225 4 1.7%
Grant $2,000 1 1.5%
Unspecified $1,694 11 1.3%
Education $957.78 13 0.7%

Payments by Type

General
$128,562
105 transactions
Research
$1,694
11 transactions

Top Paying Companies

Company Total Records Latest Year
AMAG Pharmaceuticals, Inc. $114,050 82 $0 (2023)
Sage Therapeutics, Inc. $4,005 3 $0 (2022)
Quidel Corporation $3,000 2 $0 (2023)
Kyowa Kirin, Inc. $2,400 1 $0 (2023)
Roche Diagnostics Corporation $2,000 1 $0 (2020)
Janssen Global Services, LLC $1,740 1 $0 (2023)
Kyowa Hakko Kirin Co., Ltd $800.00 1 $0 (2019)
Hologic, LLC $653.61 8 $0 (2018)
Vertex Pharmaceuticals Incorporated $525.00 1 $0 (2023)
Xellia Pharmaceuticals $500.00 1 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2023 $8,327 6 Kyowa Kirin, Inc. ($2,400)
2022 $42,533 11 AMAG Pharmaceuticals, Inc. ($40,202)
2020 $23,293 8 AMAG Pharmaceuticals, Inc. ($18,313)
2019 $52,369 63 AMAG Pharmaceuticals, Inc. ($51,550)
2018 $2,521 13 AMAG Pharmaceuticals, Inc. ($2,263)
2017 $1,213 15 HOLOGIC INC ($525.82)

All Payment Transactions

116 individual payment records from CMS Open Payments — Page 1 of 5

Date Company Product Nature Form Amount Type
12/21/2023 Janssen Global Services, LLC Consulting Fee Cash or cash equivalent $1,740.00 General
10/19/2023 Kyowa Kirin, Inc. Consulting Fee Cash or cash equivalent $2,400.00 General
03/10/2023 Vertex Pharmaceuticals Incorporated Consulting Fee Cash or cash equivalent $525.00 General
03/09/2023 Quidel Corporation Consulting Fee Cash or cash equivalent $1,800.00 General
03/08/2023 AMAG Pharmaceuticals, Inc. MAKENA (Drug) Travel and Lodging Cash or cash equivalent $1,362.15 General
Category: Reduction of risk for preterm birth
03/08/2023 Xellia Pharmaceuticals Consulting Fee Cash or cash equivalent $500.00 General
12/07/2022 AMAG Pharmaceuticals, Inc. MAKENA (Drug) Consulting Fee Cash or cash equivalent $36,120.00 General
Category: Reduction of risk for preterm birth
12/07/2022 AMAG Pharmaceuticals, Inc. MAKENA (Drug) Consulting Fee In-kind items and services $617.20 General
Category: Reduction of risk for preterm birth
12/07/2022 AMAG Pharmaceuticals, Inc. MAKENA (Drug) Consulting Fee In-kind items and services $59.24 General
Category: Reduction of risk for preterm birth
10/19/2022 Dexcom, Inc. Dexcom G6 Transmitter (Medical Supply) Food and Beverage In-kind items and services $25.55 General
Category: Endocrinology
10/18/2022 AMAG Pharmaceuticals, Inc. MAKENA (Drug) Consulting Fee In-kind items and services $83.72 General
Category: Reduction of risk for preterm birth
10/17/2022 AMAG Pharmaceuticals, Inc. MAKENA (Drug) Consulting Fee In-kind items and services $97.06 General
Category: Reduction of risk for preterm birth
09/21/2022 AMAG Pharmaceuticals, Inc. MAKENA (Drug) Consulting Fee Cash or cash equivalent $3,225.00 General
Category: Reduction of risk for preterm birth
09/06/2022 Bayer HealthCare Pharmaceuticals Inc. Kyleena (Drug), Mirena, Skyla Food and Beverage In-kind items and services $19.86 General
Category: Womens Health
07/11/2022 Sage Therapeutics, Inc. Consulting Fee Cash or cash equivalent $1,780.00 General
06/06/2022 Sage Therapeutics, Inc. ZULRESSO (Drug) Consulting Fee Cash or cash equivalent $445.00 General
Category: PSYCHIATRYPSYCHOLOGY
05/31/2022 Tandem Diabetes Care, Inc. t:slim X2 Insulin Pump with Control-IQ (Device) Food and Beverage Cash or cash equivalent $60.62 General
Category: Endocrinology
08/18/2020 Sage Therapeutics, Inc. ZULRESSO (Drug) Consulting Fee Cash or cash equivalent $1,780.00 General
Category: PSYCHIATRYPSYCHOLOGY
08/04/2020 Roche Diagnostics Corporation CD cobas Reagents (Device) Consulting Fee Cash or cash equivalent $2,000.00 General
Category: Centralized Diagnostics
02/22/2020 Quidel Corporation Consulting Fee Cash or cash equivalent $1,200.00 General
02/07/2020 AMAG Pharmaceuticals, Inc. MAKENA (Drug) Consulting Fee In-kind items and services $85.35 General
Category: REDUCTION OF RISK FOR PRETERM BIRTH
02/04/2020 AMAG Pharmaceuticals, Inc. MAKENA (Drug) Consulting Fee In-kind items and services $140.63 General
Category: REDUCTION OF RISK FOR PRETERM BIRTH
02/01/2020 AMAG Pharmaceuticals, Inc. MAKENA (Drug) Consulting Fee In-kind items and services $22.17 General
Category: REDUCTION OF RISK FOR PRETERM BIRTH
01/08/2020 AMAG Pharmaceuticals, Inc. MAKENA (Drug) Consulting Fee Cash or cash equivalent $16,500.00 General
Category: REDUCTION OF RISK FOR PRETERM BIRTH
01/08/2020 AMAG Pharmaceuticals, Inc. MAKENA (Drug) Consulting Fee Cash or cash equivalent $1,564.91 General
Category: REDUCTION OF RISK FOR PRETERM BIRTH

Research Studies & Clinical Trials

Study Name Company Amount Records
A Phase 2b3a, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of AMAG-423, a Digoxin Immune Fab, in Antepartum Subjects With Severe Preeclampsia AMAG Pharmaceuticals, Inc. $1,694 11

About Dr. Baha Sibai, M.D

Dr. Baha Sibai, M.D is a Obstetrics & Gynecology healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1942381926.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Baha Sibai, M.D has received a total of $130,256 in payments from pharmaceutical and medical device companies, with $8,327 received in 2023. These payments were reported across 116 transactions from 16 companies. The most common payment nature is "Consulting Fee" ($119,812).

Practice Information

  • Specialty Obstetrics & Gynecology
  • Other Specialties Critical Care Medicine, Maternal & Fetal Medicine
  • Location Houston, TX
  • Active Since 10/18/2006
  • Last Updated 01/18/2024
  • Taxonomy Code 207V00000X
  • Entity Type Individual
  • NPI Number 1942381926

Products in Payments

  • MAKENA (Drug) $100,785
  • FERAHEME (Drug) $11,439
  • ZULRESSO (Drug) $2,225
  • CD cobas Reagents (Device) $2,000
  • ALTIS (Device) $282.37
  • fFN (Device) $240.67
  • Fetal Fibronectin (Device) $165.79
  • FFN (Device) $146.48
  • INTRAROSA (Drug) $132.96
  • FETAL FIBRONECTIN (Device) $100.67
  • CERVIDIL (Drug) $81.36
  • Mirena (Drug) $80.14
  • t:slim X2 Insulin Pump with Control-IQ (Device) $60.62
  • Dexcom G6 Transmitter (Medical Supply) $25.55
  • Kyleena (Drug) $19.86
  • INJECTAFER (Drug) $18.92
  • t-slim insulin pump (Device) $13.22

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Obstetrics & Gynecology Doctors in Houston